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Key Messages
1. A cohort of Elderly Health 
Centres was examined to 
determine whether influenza 
vaccination decreased 
hospitalisation and mortality. 
2. In the influenza season, 
influenza vaccination 
reduced all-cause mortality 
by half and cardiorespiratory 
hospitalisation by a quarter. 
The extent to which influenza 
vaccination protects older 
people from serious morbidity 
and mortality needs to be 
confirmed in appropriately 
designed studies, so that scarce 
health care resources can be 
used effectively.
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Introduction
In Hong Kong, influenza-associated morbidity and mortality are similar to 
those in temperate climates.1 The World Health Organization (WHO) reports 
that influenza vaccination for older people (age ≥65 years) in the community 
may reduce hospitalisation by 25 to 39% and overall mortality by 39 to 75% 
during influenza seasons. These estimates are substantiated by reviews and meta-
analyses,2 but are increasingly controversial. First, it is difficult to reconcile them 
with seasonal influenza-related mortality,3 because such a reduction in mortality 
in older people during the main influenza season could prevent more deaths than 
are caused by influenza. Second, the plausibility of influenza vaccination being 
most effective at preventing non-specific outcomes (such as all-cause mortality) 
and least effective at preventing influenza has been questioned.2 Third, concerns 
have been raised as to whether the people most liable to die from influenza, ie 
the very old, are capable of mounting an effective immunological response to 
the vaccine.
 
 Effectiveness of influenza vaccine against influenza or influenza-like illness 
has been assessed in older people in five randomised control trials,2 whereas 
such effectiveness against hospitalisation and mortality has been obtained from 
observational studies comparing older people who volunteered for influenza 
vaccination with those who did not. This may create biases if those vaccinated 
and unvaccinated are systemically different. Observational evidence can be 
soundly based, but is not always confirmed in trials. Effectiveness of influenza 
vaccination in tropical and sub-tropical regions is less known, because most such 
research comes from temperate climates with a well-defined influenza season, 
whereas in tropical and sub-tropical regions, influenza may circulate at lower 
levels throughout the year.4 Subsequent to the severe acute respiratory syndrome 
(SARS) outbreak in Hong Kong in 2003, influenza vaccination has become 
more common among community-dwelling older people. Previously, influenza 
vaccination was only provided to older people living in institutions. This change 
enables examination of influenza vaccination in reducing morbidity and mortality 
of older people living in the community.
Methods
This study was conducted from 15 June 2006 to 15 September 2007. Since 
July 1998, 18 Elderly Health Centres have been established to deliver health 
examinations and primary care services for older adults by the Department of 
Health of Hong Kong. All elderly residents in Hong Kong aged ≥65 years were 
encouraged to enrol. This study covered all community-dwelling enrolees from 
July 1998 to December 2001. More women enrolled than men; otherwise the 
enrolees were similar to the general elderly population in terms of age, socio-
economic status, current smoking status, and hospital use. Record linkage by 
unique Hong Kong identity card numbers was used to obtain all deaths and 
admissions to public hospitals, which accounts for almost 95% of hospital use 
by older people.
 Multivariable negative binomial and Poisson regression was used to compare 
the risk of hospital admission or death in this cohort in the 2 years prior to SARS 
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(2001/2) and the 2 years after SARS (2004/5). Relative 
risks (incident rate ratios) with 95% confidence intervals 
were reported. The exposure was the length of time the 
Elderly Health Centre client was potentially exposed to 
influenza infection in 2001-2 and/or 2004-5, ie the duration 
of survival in each period. Exposure time started at the 
beginning of the relevant period, but at least one year after 
enrolment, because an older person capable of attending the 
Elderly Health Centre is unlikely to die immediately from 
a complication of influenza. As the same person may have 
exposure in both periods, which artefactually reduces the 
variance, we used the average estimates and standard errors 
from 100 different random splits of the cohort into two 
equally sized halves. Patient age, sex, education levels, and 
smoking status were adjusted for. 
 Different associations in potentially more vulnerable 
groups, such as older people, from the heterogeneity of 
effect across strata and the significance of interaction terms 
were examined, as were different associations in people 
receiving financial assistance (CSSA) or in poor health, 
because these people might be more likely to have been 
vaccinated. Admission and mortality in the high and low 
influenza seasons were compared. Based on surveillance 
data,4 the influenza high season was defined as 3 months 
from 1 February in 2001, 2004, and 2005 and from 1 
January in 2002. The influenza low season was defined as 3 
months from 1 September in all 4 years. A telephone survey 
was carried out to check the vaccination rate in the Elderly 
Health Centre cohort.
 This study obtained ethical approval from the Joint 
Institutional Review Board of The University of Hong 
Kong and Hospital Authority West Cluster, and the Ethics 
Committee of the Department of Health, Hong Kong.
Results
In a telephone survey from October 2006 to January 2007, 
of 286 randomly selected Elderly Health Centre enrolees, 
207 (72%) responded; 6% reported an influenza vaccination 
in 2000 to 2002, and 36% in 2003 to 2005. There were 66 
820 enrolees at the Elderly Health Centres between July 
1998 and December 2001. After excluding 2630 living 
in institutions, 742 who had died before the start of 2001 
or within one year of enrolling, and 145 with no date of 
death, 63 105 remained. Of these, 17 324 were admitted to 
hospital and 1582 died in 2001/2; 60 393 survived to the 
start of 2004, of whom 19 489 were admitted to hospital 
and 2546 died in 2004/5. 
 Overall, adjusted admissions for any cause were lower 
in the 2 years after SARS, with fewer admissions for injury 
and poisoning (Table), but not pneumonia or respiratory 
disease. Mortality was similar in both periods, including for 
injury and poisoning. In the younger age-group, admission 
was lower for cardiovascular and cardiorespiratory 
diseases. There was no evidence of different patterns for 
cardiorespiratory admissions or all-cause mortality by 
smoking status, self-rated health, overall health status or 
CSSA status either for all ages or for the younger age-group. 
 Comparing cardiorespiratory admissions and all-cause 
mortality by age-group for each possible pair of years in the 
high and low influenza seasons, there was no discernable 
pattern of reductions in the high influenza season which 
were not evident in the low influenza season (Fig).
Discussion
After the SARS outbreak in 2003, the influenza vaccination 
Table. Adjusted relative risks* (incident rate ratios) for numbers of admission and mortality in 2004/5 (post-SARS) versus in 
2001/2 (pre-SARS) by cause and age-group in the Elderly Health Centre Cohort
Variable Incident rate ratio (95% CI)
All ages 65-74 years ≥75 years
No. of admission (ICD9 CM codes)
Cancer (140-239) 1.02 (0.88-1.18) 1.03 (0.82-1.28) 1.00 (0.82-1.22)
Cardiovascular (390-459) 0.94 (0.88-1.01) 0.88 (0.78-0.97) 1.01 (0.91-1.11)
Respiratory (11 & 460-519) 0.96 (0.88-1.05) 0.91 (0.78-1.06) 1.01 (0.90-1.13)
Pneumonia (480-487) 3.10 (1.87-5.13) 2.49 (1.17-5.31) 3.54 (1.75-7.16)
Cardiorespiratory 0.95 (0.90-1.01) 0.89 (0.82-0.99) 1.01 (0.93-1.10)
Injury & poisoning (800-999 or E codes) 0.83 (0.78-0.89) 0.81 (0.71-0.92) 0.86 (0.77-0.96)
All other 0.88 (0.85-0.92) 0.84 (0.80-0.89) 0.93 (0.88-0.98)
All 0.91 (0.88-0.95) 0.87 (0.83-0.92) 0.96 (0.92-1.01)
Mortality (ICD10 codes)
Cancer (C00 to D49) 1.04 (0.90-1.19) 1.06 (0.83-1.34) 1.02 (0.85-1.22)
Cardiovascular (I00-I99) 0.97 (0.82-1.15) 0.72 (0.56-0.93) 1.08 (0.86-1.34)
Respiratory (J00-J99 except J969 and A162, A165, A168, A169) 1.40 (0.98-2.00) 1.08 (0.62-1.87) 1.50 (0.99-2.27)
Pneumonia (J09-J18) 1.63 (0.92-2.88) 1.68 (0.35-8.14) 1.61 (1.52-1.71)
Cardiorespiratory 1.11 (0.95-1.29) 0.83 (0.65-1.05) 1.22 (0.99-1.50)
Injury & poisoning (S00-T98) 1.06 (0.58-1.94) 1.22 (0.36-4.19) 1.03 (0.50-2.14)
All other 1.11 (0.84-1.46) 1.01 (0.61-1.70) 1.14 (0.82-1.58)
All 1.07 (0.97-1.18) 0.97 (0.83-1.14) 1.12 (0.99-1.26)
* Model adjusted for sex, age, education level, and smoking status
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rate in community-dwelling older people increased from 
low levels to over 35%. Influenza activity in Hong Kong 
peaked early in the year and dipped in the autumn. In the 
Elderly Health Centre cohort, there was an 11% reduction 
in cardiorespiratory hospitalisation in older people aged 65 
to 74 years, and possibly a 28% reduction in cardiovascular 
mortality in the same age-group in the 2 years (2004/5), 
with more widespread influenza vaccination. These 
findings are consistent with a review suggesting that 
influenza vaccination reduces hospitalisation for respiratory 
diseases by 22%, for cardiac diseases by 24%, and for all-
cause mortality by 48%.2 Nonetheless, in our study, there 
was no change in all-cause mortality, with a plausible no 
change in injury and poisoning mortality. An alternative 
interpretation is that the reduction in hospital use is not 
causally related to influenza vaccination. First, there 
was also a similar reduction in hospitalisation for causes 
other than cancer, respiratory disease, and cardiovascular 
disease and a larger reduction for injury and poisoning. 
Moreover, reductions were not specific to the high influenza 
seasons. Second, following the SARS outbreak more 
attention in Hong Kong has been focused on preventing 
the spread of infections, which could lead to lower disease 
transmission. Third, an 11% reduction in cardiorespiratory 
hospitalisation is equivalent to an absolute decrease of 
566 hospitalisation per 100 272 person years, whereas the 
number of cardiorespiratory hospitalisation due to influenza 
is estimated at 723 per 100 000 person years.5 Reducing the 
number of cardiorespiratory hospitalisation due to influenza 
by 78% when vaccinating 36% of the cohort seems unlikely. 
Nevertheless, the possibility of a smaller beneficial effect 
of vaccination on hospitalisation cannot be ruled out. In 
addition, we were not able to consider less serious illnesses 
not requiring hospitalisation, which may make a difference 
to an older person’s quality of life. 
Limitations
First, this study was limited by lack of information on 
individual vaccination records, which are not centrally 
accessible. Those unvaccinated in the first period were not 
unvaccinated by self-selection, but by a policy decision, thus 
removing some of the potential volunteer bias. It is possible 
that mainly ‘healthy users’ who were not susceptible to the 
complications of influenza received vaccination, although 
vaccination was targeted at the needy and those with 
chronic diseases and there was no evidence of different 
effects by health status. Second, the study only considered a 
limited number of influenza seasons, which are not directly 
comparable. Nonetheless, the seasons in 2002 and 2004 
appear similar, and a comparison of these influenza seasons 
found little difference in hospitalisation or mortality. The 
influenza strains in circulation have not changed greatly 
in several years,3 so many older people may have already 
acquired natural immunity. Third, hospitalisation and death 
rates for pneumonia were higher post-SARS, which could 
represent an increase in pneumonia or more likely greater 
vigilance and more complete ascertainment of pneumonia. 
Finally, the model may be mis-specified, however, 
hospitalisation for cancer was similar in both periods, as 
were deaths from injury and poisoning. 
Conclusions
Influenza vaccination may be beneficial and may protect 
older people from morbidity and mortality, but it is 
unlikely that influenza vaccination in Hong Kong would 
reduce all-cause mortality in the influenza season by half, 
or cardiorespiratory hospitalisation by a quarter. To what 
extent influenza vaccination protects older people in sub-
tropical regions from serious morbidity and mortality needs 
Fig. Adjusted relative risks (incident rate ratios) for (a) cardiorespiratory admission and (b) all-cause mortality in the high and low 
influenza seasons by age-group for each possible of years
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to be confirmed in appropriately designed studies, so that 
scarce health care resources can be used effectively.
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